Annual CFO
-$88.35 M
-$102.40 M-728.72%
31 December 2023
Summary:
Century Therapeutics annual cash flow from operations is currently -$88.35 million, with the most recent change of -$102.40 million (-728.72%) on 31 December 2023. During the last 3 years, it has fallen by -$47.08 million (-114.08%). IPSC annual CFO is now -728.72% below its all-time high of $14.05 million, reached on 31 December 2022.IPSC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$28.33 M
-$1.00 M-3.66%
30 September 2024
Summary:
Century Therapeutics quarterly cash flow from operations is currently -$28.33 million, with the most recent change of -$1.00 million (-3.66%) on 30 September 2024. Over the past year, it has dropped by -$14.68 million (-107.58%). IPSC quarterly CFO is now -132.66% below its all-time high of $86.75 million, reached on 31 March 2022.IPSC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$112.14 M
-$14.68 M-15.07%
30 September 2024
Summary:
Century Therapeutics TTM cash flow from operations is currently -$112.14 million, with the most recent change of -$14.68 million (-15.07%) on 30 September 2024. Over the past year, it has dropped by -$27.12 million (-31.89%). IPSC TTM CFO is now -662.68% below its all-time high of $19.93 million, reached on 31 March 2022.IPSC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -728.7% | -107.6% | -31.9% |
| 3 y3 years | -114.1% | -18.1% | -44.0% |
| 5 y5 years | - | - | - |
IPSC Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -728.7% | +0.7% | -132.7% | +6.3% | -662.7% | at low |
| 5 y | 5 years | -728.7% | +0.7% | -132.7% | +6.3% | -662.7% | at low |
| alltime | all time | -728.7% | +0.7% | -132.7% | +6.3% | -662.7% | at low |
Century Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$28.33 M(+3.7%) | -$112.14 M(+15.1%) |
| June 2024 | - | -$27.33 M(-9.6%) | -$97.46 M(+9.0%) |
| Mar 2024 | - | -$30.25 M(+15.3%) | -$89.38 M(+1.2%) |
| Dec 2023 | -$88.35 M(-728.7%) | -$26.23 M(+92.2%) | -$88.35 M(+3.9%) |
| Sept 2023 | - | -$13.65 M(-29.1%) | -$85.03 M(-11.1%) |
| June 2023 | - | -$19.25 M(-34.1%) | -$95.61 M(-6.2%) |
| Mar 2023 | - | -$29.22 M(+27.6%) | -$101.92 M(-825.3%) |
| Dec 2022 | $14.05 M | -$22.91 M(-5.5%) | $14.05 M(+11.5%) |
| Sept 2022 | - | -$24.24 M(-5.2%) | $12.61 M(-2.0%) |
| June 2022 | - | -$25.56 M(-129.5%) | $12.86 M(-35.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $86.75 M(-456.3%) | $19.93 M(-122.4%) |
| Dec 2021 | -$89.00 M(+115.7%) | -$24.35 M(+1.5%) | -$89.00 M(+14.3%) |
| Sept 2021 | - | -$23.98 M(+29.7%) | -$77.87 M(+23.4%) |
| June 2021 | - | -$18.49 M(-16.6%) | -$63.11 M(+11.6%) |
| Mar 2021 | - | -$22.18 M(+67.8%) | -$56.56 M(+37.1%) |
| Dec 2020 | -$41.27 M(+155.3%) | -$13.22 M(+43.3%) | -$41.27 M(+47.1%) |
| Sept 2020 | - | -$9.22 M(-22.7%) | -$28.05 M(+49.0%) |
| June 2020 | - | -$11.94 M(+73.4%) | -$18.82 M(+173.4%) |
| Mar 2020 | - | -$6.88 M | -$6.88 M |
| Dec 2019 | -$16.17 M | - | - |
FAQ
- What is Century Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Century Therapeutics?
- What is Century Therapeutics annual CFO year-on-year change?
- What is Century Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Century Therapeutics?
- What is Century Therapeutics quarterly CFO year-on-year change?
- What is Century Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Century Therapeutics?
- What is Century Therapeutics TTM CFO year-on-year change?
What is Century Therapeutics annual cash flow from operations?
The current annual CFO of IPSC is -$88.35 M
What is the all time high annual CFO for Century Therapeutics?
Century Therapeutics all-time high annual cash flow from operations is $14.05 M
What is Century Therapeutics annual CFO year-on-year change?
Over the past year, IPSC annual cash flow from operations has changed by -$102.40 M (-728.72%)
What is Century Therapeutics quarterly cash flow from operations?
The current quarterly CFO of IPSC is -$28.33 M
What is the all time high quarterly CFO for Century Therapeutics?
Century Therapeutics all-time high quarterly cash flow from operations is $86.75 M
What is Century Therapeutics quarterly CFO year-on-year change?
Over the past year, IPSC quarterly cash flow from operations has changed by -$14.68 M (-107.58%)
What is Century Therapeutics TTM cash flow from operations?
The current TTM CFO of IPSC is -$112.14 M
What is the all time high TTM CFO for Century Therapeutics?
Century Therapeutics all-time high TTM cash flow from operations is $19.93 M
What is Century Therapeutics TTM CFO year-on-year change?
Over the past year, IPSC TTM cash flow from operations has changed by -$27.12 M (-31.89%)